American Society for Transplantation and Cellular Therapy Series #9: Management of Human Herpesvirus 6B After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T-Cell Therapy.

Saved in:
Bibliographic Details
Title: American Society for Transplantation and Cellular Therapy Series #9: Management of Human Herpesvirus 6B After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T-Cell Therapy.
Authors: Kampouri E; Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Handley G; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas., Phan TL; Department of Internal Medicine, Division of Hematology and Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Lee YJ; Department of Medicine, Infectious Diseases Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medicine, New York, New York., Shaw R; Department of Pharmacy, University of North Carolina, Chapel Hill, North Carolina., Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington., Dadwal SS; Department of Medicine, Division of Infectious Disease, City of Hope National Medical Center, Duarte, California., Chemaly RF; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas., Papanicolaou GA; Department of Medicine, Infectious Diseases Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medicine, New York, New York., Ogata M; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan., Boeckh M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington., Zerr DM; Department of Pediatrics, University of Washington, Seattle, Washington; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hill JA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address: Jahill3@fredhutch.org.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2025 Aug; Vol. 31 (8), pp. 480-493. Date of Electronic Publication: 2025 May 21.
Publication Type: Journal Article; Practice Guideline
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6367
DOI:10.1016/j.jtct.2025.05.001